Printer Friendly

Rxaminer Provides Official Medicare Lower Cost Rx Drug Comparison Tool; Proactive Step to Provide Consumer Purchasing Power to Medicare.

CHICAGO -- Rxaminer (, a provider of consumer-directed prescription drug comparison tools, announced today that the Centers for Medicare and Medicaid Services (CMS) has incorporated Rxaminer's cost-comparison platform into the Medicare web site, The "Lower Cost Rx Comparison Tool" is helping Medicare recipients find lower-cost prescription drugs similar to the ones they currently take. Rxaminer creates customized prescription drug comparison tools for employers, health plans and pharmacy benefit managers. Rxaminer's drug comparison platform was specifically designed to link with Medicare's price comparison system for Medicare recipients. The platform creates detailed reports on the out-of-pocket cost and efficacy of similar drugs, which patients can review with their physicians. CMS has also recently launched "The Medicare Replacement Drug Demonstration," which allows coverage for certain drugs that were previously only covered for use in a doctor's office under Medicare Part B. This includes certain drugs for rheumatoid arthritis, multiple sclerosis, cancer, and other serious diseases.

"We started Rxaminer four years ago because we wanted uninsured patients to have the ability to compare the cost and efficacy of drugs they were paying for out of their own pockets. Since then, private and public insurance providers are becoming more consumer-centric. Payors, providers and patients want to know what drugs cost and what the options are," said Toby Rogers, President of Rxaminer. "By taking an active, consumer-centric role, Medicare, employers, health plans, and other payors can compare and save on the cost of their prescription drugs."

In a recent statement, Tommy Thompson, U.S. Secretary of Health and Human Services, stated, "We are creating greater competition among drug companies and making the price of prescription drugs more transparent -- giving seniors more power to compare prices and choose the lowest cost medicine that's right for them."

CMS Administrator Dr. Mark B. McClellan added, "Many widely-used drugs for common health problems often have similar effects, but rarely do consumers have good information on how their prices compare. Only physicians can decide what drug is best for their patient. We want to help patients and their physicians find the least costly way to get the health benefits that prescription drugs can provide -- including an informed discussion about whether a less expensive, similar drug is right for them."

The "Lower Cost Rx Comparison Tool" -- accessible at or by calling 1-800-MEDICARE -- will help consumers compare lower-cost prescription drugs by category (e.g., cholesterol lowering drugs, blood pressure medicines, allergy medications), that are similar to the drugs they currently take and that are used to treat the same conditions.

About Rxaminer

Based in Chicago, IL, Rxaminer is a drug information resource founded in 2000. Designed and maintained by physicians and pharmacists, Rxaminer's database of prescription drugs gives insured and uninsured consumers the opportunity to control their prescription drug costs. Rxaminer provides pharmaceutical cost management tools for Medicare, pharmacy benefits managers (PBMs), insurance providers and individual employers. The consumer-friendly drug comparison system delivers Therapeutic Option, Dose-to-Dose price comparison, Direct/Indirect Generic alternative promotion, and other cost-management techniques for any existing benefit plan and formulary. Rxaminer seamlessly integrates with an existing plan through a user-friendly, private-labeled website. Plan members become agents for formulary compliance and generic utilization. Rxaminer saves employee members an average of $512/drug annually, and reduces employer prescription benefit costs by up to 20%. For more information, please visit:
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 21, 2004
Previous Article:Interactive Data Corporation Reports Third-Quarter Results and Improves 2004 Outlook; Third-quarter Revenue Increases by 10.4%; Net Income Increases...
Next Article:Invacare Corporation Reports Record Third Quarter Earnings Which Increased 13%.

Related Articles
Bad medicine.
Across the border: purchasing drugs overseas can come with a price.
Congresswoman urges repeal of 'flawed' medicare drug card law.
What's the benefit? A new federal Medicare drug plan stimulates independent actions and new ideas, but what's the future role for states?
House of cards: seniors aren't grabbing up Medicare drug discount cards as enthusiastically as expected, but card sponsors, who are still seeing...
Pricing prescription drugs.
Drug costs surged in '04, AARP says.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters